Ændringerne omfattede mild anæmi, reduceret blodpladetal, øget miltvægt og reduceret lever - og thymusvægt.
A study in pregnant cynomolgus monkeys demonstrated natalizumab-related changes in the foetus that included mild anaemia, reduced platelet counts, increased spleen weights and reduced liver and thymus weights.